Genetic Testing for Reproductive Carrier Screening and Prenatal Diagnosis - (0514) — MM 0514 | CIGNA Coverage Update

TL;DR: Cigna Healthcare modified MM 0514 — its coverage policy for genetic testing for reproductive carrier screening and prenatal diagnosis — effective September 26, 2025. Here's what billing teams need to know before that date.

Cigna Healthcare updated MM 0514, covering reproductive carrier screening and prenatal diagnosis genetic testing. This modification affects 83 CPT codes, including high-volume codes like 81443, 81412, 0400U, 81420, and 81507. If your practice bills for preconception carrier screening, prenatal aneuploidy testing, or targeted germline variant analysis, this policy directly affects your reimbursement and claim denial exposure.

Quick-Reference Table

Cigna Reproductive Carrier Screening Coverage Criteria and Medical Necessity Requirements 2025

The Cigna MM 0514 coverage policy covers genetic testing for germline gene variants — variants that originate in the egg and sperm cells and are passed down through families. The policy draws a clear line between testing that supports reproductive planning and testing that doesn't fit that purpose.

Cigna distinguishes between two broad indications. First, tests that screen for variants associated with disease or disease risk in offspring. Second, tests used for prenatal diagnosis after pregnancy has already occurred. Both categories fall under this policy, but they carry different medical necessity criteria.

For codes like 81443 (expanded carrier screening for severe inherited conditions, including cystic fibrosis, spinal muscular atrophy, and Ashkenazi Jewish-associated disorders) and 81412 (Ashkenazi Jewish associated disorders panel), Cigna considers these medically necessary when performed for preconception purposes. The same applies to 0400U, the obstetrics expanded carrier screening panel covering 145 genes by next-generation sequencing. Document the preconception context explicitly in the record. Missing that context is a fast track to a claim denial.

For prenatal diagnosis codes — including 81420 (fetal chromosomal aneuploidy genomic sequence analysis panel, circulating cell-free fetal DNA), 81507 (fetal aneuploidy trisomy 21, 18, and 13 DNA sequence analysis from maternal plasma), and 0327U (fetal aneuploidy DNA sequence analysis of selected regions using maternal plasma) — medical necessity turns on documented clinical indications. Cigna requires the criteria in the applicable coverage position criteria to be met. That language in the policy means your documentation has to match the specific criteria, not just indicate "genetic testing requested."

Prior authorization requirements for genetic testing under this policy vary by plan. Don't assume prior auth is not required for carrier screening — check Cigna's plan-level requirements before ordering, especially for expanded panel codes like 81443 and 0400U, which carry significant reimbursement exposure.

Cigna Reproductive Genetic Testing Exclusions and Non-Covered Indications

Cigna is explicit: a substantial list of genetic testing codes are considered not medically necessary under MM 0514. These are tests that may be valid in other clinical contexts but don't meet Cigna's criteria when billed in the reproductive carrier screening or prenatal diagnosis setting.

The not-covered list includes oncology-adjacent codes that sometimes get pulled into genetic testing orders. CPT 81201, 81202, and 81203 — APC gene analysis for familial adenomatous polyposis — are not covered under this policy. Neither are 81206, 81207, and 81208 for BCR/ABL1 translocation analysis. These are leukemia markers. Billing them under reproductive carrier screening indications will not survive a Cigna audit.

Other explicitly excluded codes include 81210 (BRAF analysis), 81265 and 81266 (STR marker comparative analysis), 81275 (KRAS analysis), 81288 (MLH1 analysis), 81291 (MTHFR analysis), 81301 (microsatellite instability analysis), 81374 and 81377 (HLA Class I and II typing, low resolution), and 81381 and 81383 (HLA Class I and II typing, high resolution).

The MTHFR exclusion is worth flagging separately. CPT 81291 for MTHFR analysis is already a contested code across most payers. Cigna's inclusion of it in the not-covered list under MM 0514 reinforces that billing MTHFR in a reproductive context won't fly — and likely never did.

Whole genome sequencing codes 0335U and 0336U — rare disease constitutional and heritable disorder analysis — are also considered not medically necessary under this policy. If your lab or ordering provider is running whole genome sequencing in a reproductive context and expecting Cigna coverage under MM 0514, that needs to stop before September 26, 2025.

Coverage Indications at a Glance

Cigna Reproductive Genetic Testing Billing Guidelines and Action Items 2025

CPT, HCPCS, and ICD-10 Codes for Reproductive Carrier Screening Under MM 0514

Covered CPT Codes (When Medical Necessity Criteria Are Met)

Covered When Performed for Preconception Purposes:

Not Covered / Excluded CPT Codes Under MM 0514

Note: The policy data references three additional CPT codes not fully listed above. Review the full MM 0514 policy at the Cigna source for the complete not-covered code set.

Key ICD-10-CM Diagnosis Codes

The MM 0514 policy maps to 695 ICD-10-CM codes. The full list is available via the policy source. Work with your coding team to confirm that every reproductive carrier screening and prenatal genetic testing claim uses a diagnosis code from Cigna's approved ICD-10 list for this policy. A covered CPT code paired with an unsupported ICD-10 code is still a denial.